NCT01829542

Brief Summary

The purpose of this study is to assess the impact of acute blueberry polyphenol intake on endothelial function of healthy volunteers. Specifically, the investigators plan to perform a randomised, double blind, cross-over human intervention trial using a blueberry drink to investigate the dose-dependent effects of blueberry polyphenols on blood vessel function using Flow mediated dilation (FMD) to measure endothelial function. The study will not only measure the acute effects of flavonoid ingestion on vascular reactivity but will also assess plasma polyphenol metabolite levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2012

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 11, 2013

Completed
Last Updated

April 11, 2013

Status Verified

April 1, 2013

Enrollment Period

3 months

First QC Date

April 8, 2013

Last Update Submit

April 10, 2013

Conditions

Keywords

flow-mediated dilationblueberry polyphenolsdose-dependency

Outcome Measures

Primary Outcomes (1)

  • Flow-mediated dilation

    0-1 hour after consumption

Secondary Outcomes (1)

  • plasma blueberry polyphenol metabolites

    0-1 h after consumption

Study Arms (6)

319 mg blueberry polyphenols

ACTIVE COMPARATOR

Freeze-dried blueberry powder dissolved in water

Dietary Supplement: Freeze-dried blueberry powder dissolved in water

639 mg blueberry polyphenols

ACTIVE COMPARATOR

Freeze-dried blueberry powder dissolved in water

Dietary Supplement: Freeze-dried blueberry powder dissolved in water

766 mg blueberry polyphenols

ACTIVE COMPARATOR

Freeze-dried blueberry powder dissolved in water

Dietary Supplement: Freeze-dried blueberry powder dissolved in water

1466 mg blueberry polyphenols

ACTIVE COMPARATOR

Freeze-dried blueberry powder dissolved in water

Dietary Supplement: Freeze-dried blueberry powder dissolved in water

1791 mg total blueberry polyphenols

ACTIVE COMPARATOR

Freeze-dried blueberry powder dissolved in water

Dietary Supplement: Freeze-dried blueberry powder dissolved in water

O mg blueberry polyphenols

PLACEBO COMPARATOR

Macro- and micronutrient matched control drink

Dietary Supplement: Control

Interventions

Wild blueberry freeze-dried powder dissolved in water

1466 mg blueberry polyphenols1791 mg total blueberry polyphenols319 mg blueberry polyphenols639 mg blueberry polyphenols766 mg blueberry polyphenols
ControlDIETARY_SUPPLEMENT

Macro- and micro-nutrient matched control in water

O mg blueberry polyphenols

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • years
  • Healthy
  • signed consent form

You may not qualify if:

  • Blood pressure \> 140/90 mmHg
  • Had suffered a myocardial infarction or stroke
  • Suffers from any blood-clotting disorder
  • Suffers from any metabolic disorders (e.g. diabetes or any other endocrine or liver diseases)
  • Any dietary restrictions or on a weight reducing diet
  • Allergies or intolerances to any foods
  • Smoker
  • Heavy drinker (\>21 units per week)
  • On any lipid-modifying medication
  • On any blood pressure lowering medication
  • On any medication affecting blood clotting
  • Taking high dose fish oil supplements (greater then 1 g EPA and DHA per day) or high doses of antioxidant vitamins (greater then 800 μg vitamin A, 60 mg vitamin C, 10 mg vitamin E or 400 μg beta carotene)
  • Taking probiotics, prebiotics, synbiotics, antibiotics or anti-inflammatory or blood lowering medication within a 2-month period prior to the study
  • Planning on altering consumption of vitamin supplements/fish oil capsules during the course of the study
  • Undertakes strenuous exercise \> 4 times per week for \> 1 hour per session
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hugh Sinclair Unit of Human Nutrition

Reading, Berkshire, RG6 6AP, United Kingdom

Location

Related Publications (1)

  • Rodriguez-Mateos A, Rendeiro C, Bergillos-Meca T, Tabatabaee S, George TW, Heiss C, Spencer JP. Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am J Clin Nutr. 2013 Nov;98(5):1179-91. doi: 10.3945/ajcn.113.066639. Epub 2013 Sep 4.

MeSH Terms

Interventions

Water

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 8, 2013

First Posted

April 11, 2013

Study Start

May 1, 2012

Primary Completion

August 1, 2012

Study Completion

October 1, 2012

Last Updated

April 11, 2013

Record last verified: 2013-04

Locations